ABANDONED – EXPRESS AFTER PUB
on 19 Nov 2002
Last Applicant/ Owned by
235 East 42nd Street
New York
NY
10017
Serial Number
76340779 filed on 19th Nov 2001
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BALENCIA
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseas Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations and preparations for the treatment of gynecological disorders
Mark Details
Serial Number
No 76340779
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Nov 2002 | ABANDONMENT - AFTER PUBLICATION |
| 13th Aug 2002 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 09th Jul 2002 | PUBLISHED FOR OPPOSITION |
| 19th Jun 2002 | NOTICE OF PUBLICATION |
| 26th Feb 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 19th Feb 2002 | EXAMINER'S AMENDMENT MAILED |
| 07th Feb 2002 | ASSIGNED TO EXAMINER |
| 05th Feb 2002 | ASSIGNED TO EXAMINER |